Empowered Funds’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.3M Buy
63,530
+5,555
+10% +$1.6M 0.21% 95
2025
Q1
$17.9M Buy
57,975
+36,443
+169% +$11.2M 0.25% 68
2024
Q4
$7.6M Sell
21,532
-2,697
-11% -$952K 0.11% 246
2024
Q3
$8.68M Sell
24,229
-25,412
-51% -$9.11M 0.14% 180
2024
Q2
$15.8M Buy
49,641
+7,884
+19% +$2.51M 0.27% 53
2024
Q1
$9.59M Buy
41,757
+19,073
+84% +$4.38M 0.17% 131
2023
Q4
$4.99M Sell
22,684
-2,799
-11% -$615K 0.13% 233
2023
Q3
$5.76M Buy
+25,483
New +$5.76M 0.17% 137
2023
Q2
Sell
-10,917
Closed -$2.44M 1180
2023
Q1
$2.44M Buy
+10,917
New +$2.44M 0.14% 191
2022
Q3
Sell
-18,439
Closed -$4.35M 381
2022
Q2
$4.35M Buy
+18,439
New +$4.35M 0.56% 43
2021
Q2
Sell
-18,781
Closed -$2.85M 306
2021
Q1
$2.85M Hold
18,781
0.55% 38
2020
Q4
$2.85M Sell
18,781
-8,670
-32% -$1.32M 0.55% 38
2020
Q3
$2.77M Buy
27,451
+5,668
+26% +$573K 0.87% 41
2020
Q2
$2.64M Buy
+21,783
New +$2.64M 1.02% 25
2019
Q4
Sell
-26,196
Closed -$2.09M 141
2019
Q3
$2.09M Buy
26,196
+1,236
+5% +$98.6K 0.91% 40
2019
Q2
$1.95M Buy
24,960
+3,023
+14% +$236K 0.81% 44
2019
Q1
$2.58M Buy
+21,937
New +$2.58M 0.92% 18
2018
Q1
Sell
-16,924
Closed -$2.5M 121
2017
Q4
$2.5M Buy
16,924
+3,703
+28% +$548K 1.26% 10
2017
Q3
$1.55M Buy
13,221
+534
+4% +$62.6K 1.01% 44
2017
Q2
$1.65M Buy
12,687
+2,018
+19% +$262K 1.33% 29
2017
Q1
$1.44M Buy
+10,669
New +$1.44M 1.48% 39